Global

Surveying the clinical trial landscape.

The J&J vaccine is the first vaccine to show efficacy given as a single dose.

Millions of people are now being immunized with mRNA vaccines from Pfizer-BioNTech and Moderna. Both vaccines have very high efficacy and look safe in the short-term.

Video Chat - Streamed live Feb 18th.

How can pharmaceutical companies successfully apply advanced analytics?

Middle-income countries have gained greater access to a variety of needed cardiovascular medicines, but remain unable to close the gap with wealthy nations.

How the rampant spread of the coronavirus allows for a greater number of mutations, and what that means for the effort to use vaccines to bring an end to the pandemic.

The sudden rush of announcements was in stark contrast to increasing concerns that COVAX was faltering.

The COVAX facility - co-led by the World Health Organization, the GAVI vaccine alliance and others - earlier this month allocated around 330 million doses of COVID-19 vaccines for poorer countries.

The COVID-19 pandemic doesn’t end with a vaccine. It ends when everyone can get one.

The botched COVID-19 vaccination campaign is a great illustration of why our current capitalist system does not work.

This study demonstrates the real-world effectiveness of COVID-19 vaccines.

Though they were warned, pharmaceutical companies refused to invest in coronavirus research until it was too late.

More striking, the researchers said, was that of the 230 trials they examined — encompassing some 220,000 people — more than 40% did not record participants’ race and about 65% did not report their ethnicity.

French President Emmanuel Macron​ called on Thursday for the US​ and European nations to allocate up to 5% of current vaccine​ supplies to developing countries.